Cross-sectional study of host immune responses stimulated by bifidobacteria and lactobacilli in relation to intestinal microbiota and lifestyle - Cross-sectional study of host immune responses stimulated by bifidobacteria and lactobacilli in relation to intestinal microbiota and lifestyle

MORINAGA MILK INDUSTRY CO.,LTD.0 sites60 target enrollmentAugust 25, 2023

Conditionsone

Overview

No summary available.

Registry

who.int

Start Date

August 25, 2023

End Date

November 30, 2023

Last Updated

2 years ago

Study Type

Observational

Sex

All

Sponsor

•1\)Subjects with serious disorders on malignant tumors, respiratory disease, hepatic, kidney, cardiac, lung, digestive organs, blood, endocrine system and metabolic system, or related severe past medical histories 2\)Subjects with medication allergy, food allergy, or serious history of these 3\)Subjects who are pregnant, under lactation or expecting to be pregnant during this study 4\)Subjects with suffering from autoimmune diseases 5\)Subjects who plan to use drugs that may affect immune response and intestinal flora (antiallergic agents, anti\-inflammatory agents, antibiotics, drugs for digestive system treatment, diabetes drugs) from the time consent is obtained to the end of the study. 6\)Subjects who plan to be vaccinated against influenza, COVID\-19, or other infectious diseases from the time consent is obtained to the end of the study. 7\)Any candidates considered to be inappropriate for this study by the principal investigator based on their background, physical examination, etc.